Page last updated: 2024-10-22

aminoglutethimide and Peritoneal Carcinomatosis

aminoglutethimide has been researched along with Peritoneal Carcinomatosis in 1 studies

Aminoglutethimide: An aromatase inhibitor that is used in the treatment of advanced BREAST CANCER.
aminoglutethimide : A dicarboximide that is a six-membered cyclic compound having ethyl and 4-aminophenyl substituents at the 3-position.

Research Excerpts

ExcerptRelevanceReference
"Aminoglutethimide (AG) was administered as palliative therapy in 112 patients with metastatic breast cancer."7.67Aminoglutethimide in patients with metastatic breast cancer. ( Dao, TL; Nemoto, T; Patel, JK; Rosner, D, 1989)
"Aminoglutethimide (AG) was administered as palliative therapy in 112 patients with metastatic breast cancer."3.67Aminoglutethimide in patients with metastatic breast cancer. ( Dao, TL; Nemoto, T; Patel, JK; Rosner, D, 1989)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Nemoto, T1
Rosner, D1
Patel, JK1
Dao, TL1

Other Studies

1 other study available for aminoglutethimide and Peritoneal Carcinomatosis

ArticleYear
Aminoglutethimide in patients with metastatic breast cancer.
    Cancer, 1989, May-01, Volume: 63, Issue:9

    Topics: Adult; Aged; Aminoglutethimide; Bone Neoplasms; Breast Neoplasms; Drug Administration Schedule; Fema

1989